hepatocellular-carcinoma

Documents about hepatocellular-carcinoma

• Study in Asia of the Combination of TACE With Sorafenib in HCC Patients#845511ClinicalTrials.gov
• Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC#868361ClinicalTrials.gov
• Evaluation of Liver Regeneration With Autologous Peripheral Stem Cells#870428ClinicalTrials.gov
• TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection#875257ClinicalTrials.gov
• HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC#875513ClinicalTrials.gov
• Estimation of Functional Liver Reserve Using Cholinesterases#877571ClinicalTrials.gov
• TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCC#880913ClinicalTrials.gov
• Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC#885981ClinicalTrials.gov
• Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation#895986ClinicalTrials.gov
• Effect of Low Tidal Ventilation on Intraoperative Bleeding in Laparoscopic Major Hepatectomy#899253ClinicalTrials.gov
• Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures#902013ClinicalTrials.gov
• Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial#907610ClinicalTrials.gov
• A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers#907664ClinicalTrials.gov
• TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension#867060ClinicalTrials.gov
• FAPI PET Imaging - An Exploratory Study#870195ClinicalTrials.gov
• A prognostic model utilizing disulfidptosis-related long noncoding RNAs to differentiate pathological grades in hepatocellular carcinoma: functional analysis of AL031985.3.#165633NCBI PubMed Central
• Spatial transcriptomic-metabolic features of tumor foci and tumor capsule in microvascular invasion with hepatocellular carcinoma: A spatial multi-omics study.#193491NCBI PubMed Central
• Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF Cohort#280440HAL (France)
• Primary liver cancer at tertiary healthcare facility in Guinea: a cross-sectional study#284225HAL (France)
• An assessment of the hepatotoxic and hepatocellular carcinoma risks from aflatoxin B1 and fumonisin B1 exposure in women from Harare, Zimbabwe#329014African Journals Online
• Radiomics-Based AI for the Diagnosis and Prognosis of Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.#340368NCBI PubMed Central
• Development and validation of a nomogram based on tumor margin irregularity and alpha-fetoprotein for predicting microvascular invasion in hepatocellular carcinoma.#360585NCBI PubMed Central
• A mitochondrial function-based prognostic model for hepatocellular carcinoma uncovers MRPS15 as a key driver of tumor progression through oxidative phosphorylation.#368182NCBI PubMed Central
• A Machine Learning-Based Nomogram for Predicting Overall Survival in BCLC Stage 0-B Hepatocellular Carcinoma Patients with Low HALP Score.#406418NCBI PubMed Central
• A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection#407739ClinicalTrials.gov
• Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer#442097ClinicalTrials.gov
• From black-box prediction to transparent insight: the status quo and paradigm shift of explainable artificial intelligence in hepatocellular carcinoma research.#449833NCBI PubMed Central
• Processing enhances the anti-hepatocellular carcinoma effect of Momordicae Semen via remodeling chemical composition and regulating the Akt/mTOR/STAT3 pathway.#457629NCBI PubMed Central
• Preoperative gut microbiota combined with machine learning for predicting post-hepatectomy liver failure in HBV-related hepatocellular carcinoma: a pilot study.#476890NCBI PubMed Central
• Performance of Artificial Intelligence Models in Predicting Responsiveness of Hepatocellular Carcinoma to Transarterial Chemoembolization (TACE): A Systematic Review and Meta-Analysis.#615770NCBI PubMed Central
• Identification of a cholesterol metabolism-related signature based on KIF20A and NDC80 for prognostic stratification and immunotherapy prediction in hepatocellular carcinoma.#645289NCBI PubMed Central
• EPAS1 Adaptive Loss-of-Function Variants as Germline Determinants of Primary Antiangiogenic TKI Resistance in High-Altitude Hepatocellular Carcinoma: A Translational Pharmacogenomic Study#657294bioRxiv / medRxiv
• AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)#802625ClinicalTrials.gov
• Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation#803326ClinicalTrials.gov
• Trial of TRC105 and Sorafenib in Patients With HCC#811884ClinicalTrials.gov
• Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion#828306ClinicalTrials.gov
• Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis#833612ClinicalTrials.gov
• A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care#849112ClinicalTrials.gov
• FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation#875450ClinicalTrials.gov
• Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment#882626ClinicalTrials.gov
• Machine learning-based prediction of hepatocellular carcinoma risk in steatotic liver disease: A nationwide cohort study#236532PLOS
• Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection#283057ClinicalTrials.gov
• Tumor-associated M2 macrophages promote prostate cancer invasion through the M-CSF-PCLAF pathway#302047PLOS
• Pre-treatment CEMRI habitat radiomics and deep learning for noninvasive prediction of the VETC pattern in hepatocellular carcinoma: an exploratory radiogenomic analysis.#360586NCBI PubMed Central
• The evolving landscape of early diagnosis for hepatocellular carcinoma: a bibliometric analysis of global research trends (2016-2026) based on WoSCC database.#368059NCBI PubMed Central
• Graphical machine learning for precision medicine: radiomic analysis of hepatocellular carcinoma. (Machine learning graphique pour la médecine de précision: analyse radiomique du carcinome hépatocellulaire).#489482DBLP
• Metabolic Reprogramming of NSUN2-Mediated m(5)C Modification Promotes the Progression of Hepatocellular Carcinoma by Restricting Natural Killer Cell-Mediated Cytotoxicity.#630977NCBI PubMed Central
• Predictive value of an AI model integrating MRI radiomics and clinical features for early recurrence of hepatocellular carcinoma prior to radiofrequency ablation.#636335NCBI PubMed Central
• Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC#800225ClinicalTrials.gov
• Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)#830363ClinicalTrials.gov